Chief Medical Officer, NICE



The National Institute for Health and Care Excellence (NICE) is an internationally-recognised and highly prestigious organisation which continually improves outcomes for patients using the NHS and other public health and social care services by producing trusted, independent, and evidence-based guidance for practitioners across health, public health, and social care. Since its foundation as an independent non-departmental government body in 1999, NICE has endeavored to put “science and evidence at the heart of health and care decision-making”.

However, with new treatments, practices and technologies in the field of medicine emerging at an unprecedented pace, NICE recognises the need to rethink its role in the healthcare ecosystem – particularly given the impact that the pandemic has had, and will continue to have, on health inequalities for years to come. With a new Chief Executive (Dr. Sam Roberts – formerly the Director of Innovation, Research and Life Sciences at NHS England) at its helm, NICE has developed a five-year strategy to equip itself not only to continue to meet the needs of both patients and practitioners, but to pro-actively anticipate, recognise, and respond to the challenges and opportunities arising from new medical, technological and scientific advancements with an accelerated sense of pace and dynamism.

The Institute is therefore seeking to appoint a Chief Medical Officer (CMO) who will play a vital role in the pursuit of NICE’s goal to initiate (and sustain) a wholesale transformation of the way in which its guidelines are used by clinicians and the public – ultimately creating a future in which the translation of scientific and technological innovation into health and care is hastened and democratised across the health and care system.

As the Board’s senior professional advisor, the CMO will provide visible medical leadership and represent NICE across the health and care system, establishing the Institute’s relationships with key stakeholders and academic groups, as well as leading on external engagement to influence the uptake of NICE guidance across national, international, regional and local health and care systems. The role holder will also serve as the executive lead for horizon scanning and topic selection, identifying key changes in the evidence base and potential improvements in care across a broad range of clinical disciplines to ensure the impact of NICE’s advice is maximised. This is a wonderful opportunity to advise the Board of an organisation that has already proven its ability to work seamlessly across boundaries in order to hasten the speed of access to the latest, most effective treatments during the Covid-19 pandemic, but is now seeking to embed this agile approach for the long term.

In this appointment, NICE are looking for a senior clinical leader with extensive knowledge of the UK health, social care, and public health ecosystems, who can balance a forward-thinking approach with an appreciation for the Institute’s history and achievements to date. Through their personal credibility, influence, and communication skills, the role holder will have the ability to build strong relationships with a diverse set of senior stakeholders, ensuring that NICE’s vision for the future is properly articulated and represented externally and that patient safety is always at the core of the Institute’s activities. Given the dual responsibility that the CMO will also hold for all medical consultant staff (including accountability for clinical governance, revalidation, and fulfilling the role of the Caldicott Guardian), the Board is also seeking a people-centric leader, who can contribute to the development of high-calibre and multi-disciplinary teams across NICE.

To view the Job Specification click here. 

The MBS Group are acting as NICE’s advisors on this appointment. To apply please send a covering letter, CV, and completed Equality Monitoring Form (available in Appendix I of the candidate information pack available below) with the subject line “Application for the role of Chief Medical Officer” to nice@thembsgroup.co.uk by noon on Monday 27th June.

Please note that this is a part-time position, consisting of 22.5 hours per week (i.e. 0.6 full-time equivalent) and may be based in either London or Manchester, where NICE has offices.

The Chief Medical Officer will be appointed on either a Medical and Dental or GP employed contract and will be entitled to a salary up to £114,003 per annum pro rata plus any clinical excellence awards (CEAs) that may have been achieved up to a maximum of £150,000 pro rata. The role holder will also have membership to the NHS Superannuation Pension Scheme.